Home > Money > Report

Mashelkar report draws health groups' ire again

Priyanka Golikeri / DNA
Monday, August 17, 2009 3:16 IST
Email Email
Print Print
Share Share

Mumbai: With the government last week accepting the Mashelkar Committee Report on pharmaceutical patents, the stage is set for a new battle over patents and public health.
The report, which made headlines in 2007 for being plagiarised from a UK study funded by pharma companies, was re-submitted to the government a few months ago. It, however, carries the same conclusions as the last time, albeit with stronger reasoning.
The report notes that restricting grant of patent for a pharmaceutical substance to a new chemical entity (NCE) or new medical entity (NME) and excluding micro-organisms from the ambit of patents would not be compatible with Article 27 of the Trade Related Aspects of Intellectual Property Rights (TRIPS) agreement of the World Trade Organisation.

Going platinum
The preview of Sakti Burman's show of serigraphs was hosted by art collector Lavesh Jagasia on Monday at the Pundole Art Gallery
Girls wanna have fun
Wine connoisseur Shamita Singha hosted a wine appreciation dinner for some of her friends as she took them through a number of wines paired with a four-course meal.

Get daily news in your inbox and read it at your convenience.

D 910